Reliefband Technologies LLC (Philadelphia), a private company, reported it has raised $5 million in venture capital funding since it was established in July. The company will use the funding to fuel the consumer market introduction of Reliefband, an FDA-cleared wearable device that uses neuromodulation for the treatment of nausea.

The past year was marked with wide swings in the public market, influenced by a range of global and domestic factors, but according to Cohnreznick LLP (New York), health care and life sciences continue to represent the most active IPO sector. The firm, which provides accounting, tax and advisory services to middle market companies with market caps between $10 million and $2 billion post-IPO, said life sciences represented 47 percent of all middle market IPOs in 2015, with 63 IPOs in the industry as of Nov. 30.